Basic Information
RNALocate ID: | RLID:11001851 |
RNA Symbol: | hsa-miR-9-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-9 |
RNA ID: | miRBase:MIMAT0000441 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24009880 |
Tissue/Cell Line: | Human mast cell line (HMC-1) |
Method: | Microarray |
Description: | In the exosomes, 116 microRNAs were identified and 134 microRNAs were identified in the donor HMC-1 cells (Fig. 3a and 3b, Table I and Additional Information, Table S16). Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001806 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001807 | Mitochondrion | Cell line (HEK-293) | 22984580 |
RLID:01001808 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:11001847 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001848 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11001849 | Exosome | Brain tissue | 23382797 |
RLID:11001850 | Exosome | Plasma | 23663360 |
RLID:11001852 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11001853 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000089 | Exosome | Blood|Chronic lymphocytic leukemia cells|Tongue tissue | |
RLID-D:11000369 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-9-5p | Disease of metabolism | MNDR-E-MI-72441 |
MNDR | hsa-miR-9-5p | Splenic marginal zone lymphoma | MNDR-E-MI-72442 |
MNDR | hsa-miR-9-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-72443 |
MNDR | hsa-miR-9-5p | Oral squamous cell carcinoma | MNDR-E-MI-72444 |
MNDR | hsa-miR-9-5p | Large cell neuroendocrine cancer | MNDR-E-MI-72445 |
MNDR | hsa-miR-9-5p | Follicular lymphoma | MNDR-E-MI-72446 |
MNDR | hsa-miR-9-5p | Medulloblastoma | MNDR-E-MI-72447 |
MNDR | hsa-miR-9-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-72448 |
MNDR | hsa-miR-9-5p | Lymphoma | MNDR-E-MI-72449 |
MNDR | hsa-miR-9-5p | Lymphoma non-hodgkin | MNDR-E-MI-72450 |
MNDR | hsa-miR-9-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-72451 |
MNDR | hsa-miR-9-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-72452 |
MNDR | hsa-miR-9-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-72453 |
MNDR | hsa-miR-9-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-72454 |
MNDR | hsa-miR-9-5p | Her2-receptor positive breast cancer | MNDR-E-MI-72455 |
MNDR | hsa-miR-9-5p | Triple negative breast cancer | MNDR-E-MI-72456 |
MNDR | hsa-miR-9-5p | Anencephaly | MNDR-E-MI-72457 |
MNDR | hsa-miR-9-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-72458 |
MNDR | hsa-miR-9-5p | Gastric cancer | MNDR-E-MI-72459 |
MNDR | hsa-miR-9-5p | Gastric lymphoma | MNDR-E-MI-72460 |
MNDR | hsa-miR-9-5p | Alzheimer disease | MNDR-E-MI-72461 |
MNDR | hsa-miR-9-5p | Intracranial aneurysm | MNDR-E-MI-72462 |
MNDR | hsa-miR-9-5p | Urinary bladder cancer | MNDR-E-MI-72463 |
MNDR | hsa-miR-9-5p | Sarcoma | MNDR-E-MI-72464 |
MNDR | hsa-miR-9-5p | Dysautonomia familial | MNDR-E-MI-72465 |
MNDR | hsa-miR-9-5p | Seizures | MNDR-E-MI-72466 |
MNDR | hsa-miR-9-5p | Friedreich ataxia | MNDR-E-MI-72467 |
MNDR | hsa-miR-9-5p | Huntington disease | MNDR-E-MI-72468 |
MNDR | hsa-miR-9-5p | Chorea | MNDR-E-MI-72469 |
MNDR | hsa-miR-9-5p | Lung cancer | MNDR-E-MI-72470 |
MNDR | hsa-miR-9-5p | Endometrial cancer | MNDR-E-MI-72471 |
MNDR | hsa-miR-9-5p | Down syndrome | MNDR-E-MI-72472 |
MNDR | hsa-miR-9-5p | Parkinson disease | MNDR-E-MI-72473 |
MNDR | hsa-miR-9-5p | Basal-like breast cancer | MNDR-E-MI-72474 |
MNDR | hsa-miR-9-5p | Squamous cell carcinoma | MNDR-E-MI-72475 |
MNDR | hsa-miR-9-5p | Thyroid cancer | MNDR-E-MI-72476 |
MNDR | hsa-miR-9-5p | Malignant mesothelioma | MNDR-E-MI-72477 |
MNDR | hsa-miR-9-5p | Pancreatic cancer | MNDR-E-MI-72478 |
MNDR | hsa-miR-9-5p | Malignant melanoma | MNDR-E-MI-72479 |
MNDR | hsa-miR-9-5p | Colon cancer | MNDR-E-MI-72480 |
MNDR | hsa-miR-9-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-72481 |
MNDR | hsa-miR-9-5p | Familial ovarian cancer | MNDR-E-MI-72482 |
MNDR | hsa-miR-9-5p | Prostate adenocarcinoma | MNDR-E-MI-72483 |
MNDR | hsa-miR-9-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-72484 |
MNDR | hsa-miR-9-5p | Carcinoma ductal breast | MNDR-E-MI-72485 |
MNDR | hsa-miR-9-5p | Invasive ductal carcinoma | MNDR-E-MI-72486 |
MNDR | hsa-miR-9-5p | Glioblastoma | MNDR-E-MI-72487 |
MNDR | hsa-miR-9-5p | Glioblastoma multiforme somatic | MNDR-E-MI-72488 |
MNDR | hsa-miR-9-5p | Glioma | MNDR-E-MI-72489 |
MNDR | hsa-miR-9-5p | Oligodendroglioma | MNDR-E-MI-72490 |
MNDR | hsa-miR-9-5p | Neurilemmoma | MNDR-E-MI-72491 |
MNDR | hsa-miR-9-5p | Central nervous system lymphoma | MNDR-E-MI-72492 |
MNDR | hsa-miR-9-5p | Rhabdomyosarcoma | MNDR-E-MI-72493 |
MNDR | hsa-miR-9-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-72494 |
MNDR | hsa-miR-9-5p | Epilepsy temporal lobe | MNDR-E-MI-72495 |
MNDR | hsa-miR-9-5p | Osteosarcoma | MNDR-E-MI-72496 |
MNDR | hsa-miR-9-5p | Uterus cancer | MNDR-E-MI-72497 |
MNDR | hsa-miR-9-5p | Melas syndrome | MNDR-E-MI-72498 |
MNDR | hsa-miR-9-5p | Cervical adenocarcinoma | MNDR-E-MI-72499 |
MNDR | hsa-miR-9-5p | Gastric adenocarcinoma | MNDR-E-MI-72500 |
MNDR | hsa-miR-9-5p | Cervical squamous cell carcinoma | MNDR-E-MI-72501 |
MNDR | hsa-miR-9-5p | Pituitary adenoma | MNDR-E-MI-72502 |
MNDR | hsa-miR-9-5p | Lung squamous cell carcinoma | MNDR-E-MI-72503 |
MNDR | hsa-miR-9-5p | Carcinoma lung non-small-cell | MNDR-E-MI-72504 |
MNDR | hsa-miR-9-5p | Lung adenocarcinoma | MNDR-E-MI-72505 |
MNDR | hsa-miR-9-5p | Thyroid carcinoma | MNDR-E-MI-72506 |
MNDR | hsa-miR-9-5p | Papillary thyroid carcinoma | MNDR-E-MI-72507 |
MNDR | hsa-miR-9-5p | Brain stem cancer | MNDR-E-MI-72508 |
MNDR | hsa-miR-9-5p | Cervical cancer | MNDR-E-MI-72509 |
MNDR | hsa-miR-9-5p | Carcinoma renal cell | MNDR-E-MI-72510 |
MNDR | hsa-miR-9-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-72511 |
MNDR | hsa-miR-9-5p | Renal clear cell carcinoma | MNDR-E-MI-72512 |
MNDR | hsa-miR-9-5p | Large cell carcinoma | MNDR-E-MI-72513 |
MNDR | hsa-miR-9-5p | Cholangiocarcinoma | MNDR-E-MI-72514 |
MNDR | hsa-miR-9-5p | Esophageal cancer | MNDR-E-MI-72515 |
MNDR | hsa-miR-9-5p | Lung small cell carcinoma | MNDR-E-MI-72516 |
MNDR | hsa-miR-9-5p | Schizophrenia | MNDR-E-MI-72517 |
MNDR | hsa-miR-9-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-72518 |
MNDR | hsa-miR-9-5p | Heart failure | MNDR-E-MI-72519 |
MNDR | hsa-miR-9-5p | Uveal melanoma | MNDR-E-MI-72520 |
MNDR | hsa-miR-9-5p | Breast invasive carcinoma | MNDR-E-MI-72521 |
MNDR | hsa-miR-9-5p | Progressive supranuclear palsy | MNDR-E-MI-72522 |
MNDR | hsa-miR-9-5p | Hepatocellular carcinoma | MNDR-E-MI-72523 |
MNDR | hsa-miR-9-5p | Embryonal tumors | MNDR-E-MI-72524 |
MNDR | hsa-miR-9-5p | Familiar ovarian carcinoma | MNDR-E-MI-72525 |
MNDR | hsa-miR-9-5p | B-cell lymphoma | MNDR-E-MI-72526 |
MNDR | hsa-miR-9-5p | T-cell leukemia | MNDR-E-MI-72527 |
MNDR | hsa-miR-9-5p | Neuroblastoma | MNDR-E-MI-72528 |
MNDR | hsa-miR-9-5p | Hodgkin lymphoma | MNDR-E-MI-72529 |
MNDR | hsa-miR-9-5p | Burkitt lymphoma | MNDR-E-MI-72530 |
MNDR | hsa-miR-9-5p | Mouth neoplasms | MNDR-E-MI-72531 |
MNDR | hsa-miR-9-5p | Acute myelocytic leukemia | MNDR-E-MI-72532 |
MNDR | hsa-miR-9-5p | Colorectal cancer | MNDR-E-MI-72533 |
MNDR | hsa-miR-9-5p | Nasopharynx carcinoma | MNDR-E-MI-72534 |
MNDR | hsa-miR-9-5p | Multiple myeloma | MNDR-E-MI-72535 |
MNDR | hsa-miR-9-5p | Acute lymphocytic leukemia | MNDR-E-MI-72536 |
MNDR | hsa-miR-9-5p | Ovarian epithelial cancer | MNDR-E-MI-72537 |
MNDR | hsa-miR-9-5p | Uterine cervical neoplasms | MNDR-E-MI-72538 |
MNDR | hsa-miR-9-5p | Ependymoma | MNDR-E-MI-72539 |
MNDR | hsa-miR-9-5p | Prostatic neoplasms | MNDR-E-MI-72540 |
MNDR | hsa-miR-9-5p | Aids dementia complex | MNDR-E-MI-72541 |
MNDR | hsa-miR-9-5p | Epstein-barr virus infections | MNDR-E-MI-72542 |
MNDR | hsa-miR-9-5p | Gait ataxia | MNDR-E-MI-72543 |
MNDR | hsa-miR-9-5p | Stroke lacunar | MNDR-E-MI-72544 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCC1 | Homo sapiens | RR00023333 |
TOP